In vitro studies showed cathepsin L’s paracrine interaction with endothelial cells increases endothelial invasion, migration and sprouting while cathepsin L inhibition suppresses angiogenesis in xenograft breast cancer models (47). Here, CTSL is linked to breast carcinoma.